iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases

2009/10/24 by Satoshi Serada, Minoru Fujimoto, Atsushi Ogata +11 · 25 citations
Medicine · Chemistry · Biochemistry, Genetics and Molecular Biology · #Clusterin in disease pathology #Advanced Proteomics Techniques and Applications #S100 Proteins and Annexins

paper · doi:10.1136/ard.2009.118919

Cited by

• Proteomic analysis of the marine diatom Thalassiosira pseudonana upon exposure to benzo(a)pyrene. [europepmc]
• Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. [europepmc]
• Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry. [europepmc]
• Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex. [europepmc]
• Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach. [europepmc]
• Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma. [europepmc]
• Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis. [europepmc]
• Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells. [europepmc]
• LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF- β -Induced Angiogenesis. [europepmc]
• Retinal endothelial cell phenotypic modifications during experimental autoimmune uveitis: a transcriptomic approach. [europepmc]
• Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis. [europepmc]
• Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. [europepmc]
• Proteomics of Non-human Primate Plasma after Partial-body Radiation with Minimal Bone Marrow Sparing. [europepmc]
• Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still's Disease. [europepmc]
• Identification of Potential Biomarkers and Immune Features of Sepsis Using Bioinformatics Analysis. [europepmc]
• Inflammatory Markers in Cerebrospinal Fluid from Patients with Hydrocephalus: A Systematic Literature Review. [europepmc]
• Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease. [europepmc]
• Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study. [europepmc]
• Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease. [europepmc]
• Proteomics, Personalized Medicine and Cancer. [europepmc]
• Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1. [europepmc]
• Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. [europepmc]
• Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. [europepmc]
• Latrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function. [europepmc]
• An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial. [europepmc]